Kotak Healthcare Fund · Regular · Growth
NAV
₹16.3530
as of 15 Jul 2026
Expense Ratio
2.34%
AUM
₹462 Cr
Lumpsum returns (CAGR)
- 1Y
- +19.19%
- 3Y
- —
- 5Y
- —
- Since Inception
- +20.07%
SIP returns (XIRR)
- 1Y
- +35.94%
- 3Y
- —
- 5Y
- —
- Since Inception
- +19.32%
Returns calculated from 20 November 2023 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
We don't show backtest scenarios for this fund yet — its NAV history has an unresolved discontinuity we're still verifying. Returns above are unaffected.
Risk Metrics
Trailing 1 year, annualised0.47
Sharpe Ratio
+0.11
Alpha
0.23
Beta
0.44
Sortino
15.23%
Std Dev
-13.19%
Max Drawdown
Performance Comparison
Thinking about Kotak Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.13.01%
- 2Jb Chemicals & Pharmaceuticals Ltd.6.23%
- 3Divis Laboratories Ltd.5.95%
- 4Max Healthcare Institute Ltd.5.43%
- 5Cipla Ltd.5.00%
- 6Ami Organics Ltd4.92%
- 7Fortis Healthcare India Ltd4.31%
- 8Park Medi World Limited (Park Hospital)4.20%
- 9Mankind Pharma Ltd3.18%
- 10Krishna Institute Of Medical3.12%
Investment Objective
Kotak Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹462 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Healthcare Index (Total Return Index). The current expense ratio is 2.34%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations